Content area
Full Text
[Image omitted] - (http://www.fiercebiotech.com/story/help-eli-lilly-tvm-pushes-its-build-buy-fund-201m/2014-10-07) Closely allied with Eli Lilly ($LLY), TVM Capital Life Sciences has bumped up its latest fund past the $200 million mark with plans to bankroll up to 15 build-to-buy drug development projects.
TVM initially unveiled its TVM Life Science Ventures VII back in 2012 when Lilly and others had stepped in to finance the early-stage R&D operation. Eli Lilly set up a division of its supposedly lean-and-mean R&D arm of Chorus in Montreal with an eye to collaborating on the drugs that TVM was scouting in the biopharma industry.
That kind of build-to-buy strategy...